<DOC>
	<DOCNO>NCT01841515</DOCNO>
	<brief_summary>Prolonged Collagen/Epinephrine - closure time ( CEPI-CT ) indicate platelet dysfunction CKD patient take antiplatelet agent . The synthetic vasopressin derivative , Desmopressin ( DDAVP ) shorten prolonged bleeding time improve platelet dysfunction measure vitro closure time : CEPI-CT uremic patient . Desmopressin also antagonize vitro platelet dysfunction induce GPIIb/IIIa inhibitor , clopidogrel aspirin . The investigator design prospective study evaluate effect desmopressin platelet function , measure vitro collagen/epinephrine - closure time , uremic patient take antiplatelet drug .</brief_summary>
	<brief_title>Effect Desmopressin Platelet Function CKD Patients Antiplatelet Drug</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>adult uremic patient one antiplatelet medication , prolonged collagen/epinephrine ( CEPI ) closure time , need emergent hemodialysis subsequent catheter insertion acute coronary syndrome , hemophilia , nephrogenic diabetes insipidus , allergy desmopressin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>